Johnson & Johnson ( JNJ ) is set to release its fourth-quarter financial results next Wednesday, Jan. 21. The Wall Street consensus is for adjusted EPS of $2.49 on revenue of close to $24.2 billion. Results like that wou…
Read in context ›Johnson & Johnson Stock (JNJ)
Track Johnson & Johnson stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
JNJ
Johnson & Johnson
healthcare
At close
$237.00
▲ +4.84 (+2.08%)
Jun 9, 4:00 PM ET
Pre-market
$238.45
▲ +1.45 (+0.61%)
Jun 10, 9:13 AM ET
Market Cap
$558.86B
P/E Ratio
27.5x
1Y Return
+55.59%
EPS (TTM)
$8.65
Read the latest TheStreet Pro articles mentioning Johnson & Johnson, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
85 articlesDaily Diary Mentions
2 mentionsIs Johnson & Johnson Setting Up for an 'Explosive Move'? Procter & Gamble: Latest Example of Loss of Pricing Power * A constant refrain of ours... Procter & Gamble PG (joining McDonald's MCD , Disney DIS , Pepsi PEP , Delta Airlines DAL , Starbucks SBUX and others) becomes the latest consumer-based company to suffer from demand elast…
Read in context ›